您選擇的商品

Natco Pharma: Manufacturing Affordable Medicines

Maram Srikanth; Palanisamy Saravanan; Gunta Srinivas;

商品編號:9B18N024
出版日期:2018/11/23
再版日期:2018/11/23
商品來源:Ivey
商品主題:Entrepreneurship; Finance; International Business
商品類型:Case (Field)
涵蓋議題:optimal capital structure;cost of debt;cost of equity;bankruptcy risk;Agency Theory;Pecking Order Theory
難易度:5 - MBA/Postgraduate
內容長度:12 頁
地域:India
產業:Manufacturing;
事件年度:2015

In 2015, the chief executive officer of Natco Pharma Limited, a commercial manufacturer of pharmaceutical drugs in India, needed to raise funds either through debt or equity to meet the company's capital expenditure and working capital requirements of ?3.41 billion. The company could finance a loan at an interest rate of 12 per cent or raise funds through public deposits at an interest rate of 13 per cent. The company could also use equity to raise the requisite funds through either a rights offering or a seasoned equity offering. The chief executive officer needed to present his recommendation to the board of directors the following week. Which option should the company adopt?

教學手冊:8B18N024;
補充材料: